These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3035679)

  • 21. [Transdermal estrogenic therapy in menopause].
    Nencioni T; Polvani F; Penotti M; Porcaro E; Barbieri Carones M
    Minerva Endocrinol; 1989; 14(1):49-52. PubMed ID: 2543896
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Climacteric disturbances. 2. Therapy of climacteric disturbances].
    Döring GK
    Fortschr Med; 1976 Jul; 94(19):1118-26. PubMed ID: 184019
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of conjugated equine oestrogens and oestriol on blood clotting, plasma lipids and endometrial proliferation in post-menopausal women.
    Campagnoli C; Tousijn LP; Belforte P; Ferruzzi L; Dolfin AM; Morra G
    Maturitas; 1981 Aug; 3(2):135-44. PubMed ID: 6270507
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High progesterone receptor concentration in a variant of the ZR-75-1 human breast cancer cell line adapted to growth in oestrogen free conditions.
    van den Berg HW; Martin J; Lynch M
    Br J Cancer; 1990 Apr; 61(4):504-7. PubMed ID: 2139575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin 1 release.
    Pacifici R; Rifas L; McCracken R; Vered I; McMurtry C; Avioli LV; Peck WA
    Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2398-402. PubMed ID: 2522659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hormone replacement therapy and hypertension.
    Felmeden DC; Lip GY
    Blood Press; 2000; 9(5):246-9. PubMed ID: 11193126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oestrogens and menopausal and postmenopausal women.
    Hailes J; Burger H
    Med J Aust; 1977 May; 1(22):803-6. PubMed ID: 196165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogen replacement therapy I: a 10-year prospective study in the relationship to osteoporosis.
    Nachtigall LE; Nachtigall RH; Nachtigall RD; Beckman EM
    Obstet Gynecol; 1979 Mar; 53(3):277-81. PubMed ID: 218151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conjugated estrogen plus medroxyprogesterone does not impair blood rheological properties in hypertensive postmenopausal women.
    Sumino H; Ichikawa S; Takahashi T; Sakamoto H; Goto-Onozato K; Koya S; Kanda T; Nara M; Seki K; Murakami M; Kurabayashi M
    Maturitas; 2006 Feb; 53(3):306-14. PubMed ID: 16040211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of progestin therapy on cortical and trabecular bone: comparison with estrogen.
    Gallagher JC; Kable WT; Goldgar D
    Am J Med; 1991 Feb; 90(2):171-8. PubMed ID: 1847582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxytocinergic activity is linked to lower blood pressure and vascular resistance during stress in postmenopausal women on estrogen replacement.
    Light KC; Grewen KM; Amico JA; Brownley KA; West SG; Hinderliter AL; Girdler SS
    Horm Behav; 2005 May; 47(5):540-8. PubMed ID: 15811355
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced vaginal bleeding in postmenopausal women who receive combined norethindrone acetate and low-dose ethinyl estradiol therapy versus combined conjugated equine estrogens and medroxyprogesterone acetate therapy.
    Simon JA; Liu JH; Speroff L; Shumel BS; Symons JP
    Am J Obstet Gynecol; 2003 Jan; 188(1):92-9. PubMed ID: 12548201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of long-term oestrogen replacement therapy on glucose and lipid metabolism in postmenopausal women.
    Notelovitz M
    S Afr Med J; 1976 Nov; 50(50):2001-3. PubMed ID: 188205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential clinical response to oestrogens after menopause.
    Wren BG; Brown LB; Routledge DA
    Med J Aust; 1982 Oct; 2(7):329-32. PubMed ID: 6292676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women.
    Sherwin BB
    J Clin Endocrinol Metab; 1991 Feb; 72(2):336-43. PubMed ID: 1846872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sex steroids modulate prolactin response to naloxone in postmenopausal women.
    Melis GB; Gambacciani M; Paoletti AM; Mais V; Cagnacci A; Petacchi FD; Fioretti P
    Neuroendocrinology; 1985 Aug; 41(2):138-41. PubMed ID: 2995857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women.
    Koh KK; Mincemoyer R; Bui MN; Csako G; Pucino F; Guetta V; Waclawiw M; Cannon RO
    N Engl J Med; 1997 Mar; 336(10):683-90. PubMed ID: 9041098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biochemical studies on endometrium from postmenopausal women receiving hormone replacement therapy.
    King RJ; Whitehead MI; Campbell S; Minardi J
    Postgrad Med J; 1978; 54 Suppl 2():65-8. PubMed ID: 216982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Postmenopausal hormone therapy and blood pressure revisited.
    Pines A
    Climacteric; 2015 Feb; 18(1):104-5. PubMed ID: 25734208
    [No Abstract]   [Full Text] [Related]  

  • 40. Is Provera the ideal progestogen for addition to postmenopausal estrogen therapy?
    Lane G; Siddle NC; Ryder TA; Pryse-Davies J; King RJ; Whitehead MI
    Fertil Steril; 1986 Mar; 45(3):345-52. PubMed ID: 3005052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.